Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance.
about
Antibiotics in the clinical pipeline at the end of 2015.Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.Investigational antimicrobial agents of 2013.High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.Pipeline of Known Chemical Classes of Antibiotics.Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic AspectsThe effects of pH on wound healing, biofilms, and antimicrobial efficacy.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.Finafloxacin: first global approval.Finafloxacin for the treatment of urinary tract infections.Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in AustraliaThe efficacy of silver dressings and antibiotics on MRSA and MSSA isolated from burn patients.Population pharmacokinetics of finafloxacin in healthy volunteers and patients with complicated urinary tract infections.Efficacy and Safety of Finafloxacin versus Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections: An Explorative Randomized Phase II Clinical Study.Early clinical assessment of the antimicrobial activity of finafloxacin compared to ciprofloxacin in sub-sets of microbiologically characterized isolates.Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.
P2860
Q30249262-ECCBFCCF-AD08-450C-8417-8A3002301469Q33601794-FA0FF760-41BE-444A-9869-D2C73709808DQ33843665-0FF55D29-9224-49C1-BEBC-E905C09007B9Q34375204-6EEF1AB9-CB07-4B0D-A0DA-8519969F90D2Q36290512-5698B9D7-A495-47A8-96D6-68425CB6C6F9Q36683409-C30B9537-4A9C-444B-BA72-1185A75BDA6CQ36683661-13F9FE32-6302-4A88-A46C-CCA4E66B309BQ38194624-9BEE7054-16BF-4D81-A7D3-5841BAF30BFAQ38233471-A64A37EE-E670-4903-B0D6-AC5F542101BDQ38283158-3AD4384C-B387-4A3C-8273-FE47B44A216FQ38391019-8745DF31-CDA5-4677-ABEF-C482CB2BA293Q38526001-A7480FB0-57A5-40D9-BEF5-F65AE2EAB809Q41878231-F3665FBA-0B78-41BF-8F60-9BB660123769Q44970812-CFA78585-62CF-408B-9DD3-EB3160321CDEQ48232629-C7EC80ED-964C-4F0C-83B7-A4DB5DE49257Q50020710-C0761FDA-9DA3-4841-B6D5-237445014435Q50020716-49D6F7B0-218F-4B10-B2B5-3040A3E496D8Q53755551-8A299E07-E510-447D-8B86-591C8C897946
P2860
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@en
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@nl
type
label
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@en
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@nl
prefLabel
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@en
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@nl
P2093
P356
P1476
Antibacterial activity of fina ...... of fluoroquinolone resistance.
@en
P2093
Anke Heisig
Harald Labischinski
Nadine-C Emrich
Peter Heisig
Will Stubbings
P304
P356
10.1093/JAC/DKQ375
P407
P577
2010-10-12T00:00:00Z